ArticleEuropean journal of medical research2025
Bangerter filter's role in regulating ocular axial length: a novel application of an established therapy.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Amblyopia in 2026: A State-of-the-Art Review of Multidimensional Phenotyping, Response Heterogeneity, and Clinical Considerations.Brain sciences · 2026Review
- Optically Induced Peripheral Contrast Reduction Restores ON/OFF Pathway Balance in Myopic Eyes.Ophthalmology science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
key messagesWhat is known Occlusion with Bangerter filters designed with different translucent microscopic diffusers is an effective treatment for anisometropic amblyopia. What is new Bangerter filters were found to show an effect on slowing down ocular axial length (AL) growth. When rapid hyperopic reduction occurs in the non-amblyopic eye combined with persistently widening interocular AL differences, Bangerter filter application represents a more preferable alternative to patching for managing anisometropic amblyopia. PURPOSE: Bangerter filter occlusion is an effective clinical method for amblyopia treatment. This study aimed to compare the nonamblyopic eyes elongation and refraction change of patching and Bangerter filter occlusion in treating patients with anisometropic amblyopia and to further investigate the effect of Bangerter filter on axial length growth.
methodsThis retrospective study included 54 patients with anisometropic amblyopia categorized by initial treatment: patching group (n = 24) and Bangerter filter group (n = 30). Consecutive records of both the amblyopia and nonamblyopia eyes were reviewed from baseline before treatment onset to follow-up visits during or post-treatment, including best corrected visual acuity, pneumatic intraocular pressure, spherical equivalent refraction (SER), axial length (AL), corneal curvature, binocular visual function, and accommodative function. In addition, macrostructures of three different densities of Bangerter filters and diffusion optics technology lenses were observed and compared.
resultsThe nonamblyopic eyes in the Bangerter filter group had significantly lower AL increases from baseline (- 0.15 and - 0.20, respectively, P < 0.05) and significantly fewer SER reductions from baseline (0.45 and 0.57, respectively, P < 0.05) compared with the patching group at both two follow-up visits. The interocular AL difference between nonamblyopic and amblyopic eyes increased by 0.15 ± 0.27 mm in the occlusion group at the second follow-up (from baseline 0.23 ± 0.61 mm to second follow-up 0.38 ± 0.69 mm, P = 0.004), while it decreased by 0.18 ± 0.20 mm in the Bangerter filter group at the second follow-up (from baseline 0.72 ± 0.68 mm to second follow-up 0.54 ± 0.69 mm, P < 0.001).
conclusionsBangerter filter, as a traditional occlusion therapy, have been shown to effectively slow ocular AL growth thereby reducing interocular axial length disparity when compared to patching therapy in anisometropic amblyopia treatment. Rapid reduction of hyperopic refraction in non-amblyopic eyes combined with persistent increases in interocular AL difference may constitute a novel indication for Bangerter filter application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.